手法治疗预防偏头痛:一项随机对照试验的设计
该文报告一项在初级保健中开展的实用性随机对照试验设计,比较多模式手法治疗(MT)与全科医生常规照护对偏头痛的预防效果。受试者按国际头痛学会ICHD-III标准招募并随机分组,干预12周,随访至52周,主要结局为每4周偏头痛天数(头痛日记评估)。
要点
- 多模式MT含手法按压、颈肌力量训练及颈胸椎松动。
- 主要结局为头痛日记记录的每4周偏头痛天数。
- 试验含12周治疗期及12、26、52周随访测量。
核心结论
- 试验结果将显示多模式MT干预是否为偏头痛患者有效的非药物预防治疗选择。
研究设计与样本
- 实用性随机对照试验设计,在初级保健中按国际头痛学会ICHD-III偏头痛标准招募受试者。
- 受试者随机分为多模式MT组与全科医生常规照护组,常规组按荷兰全科医生头痛指南治疗。
- 干预含12周治疗期,随访测量在第12、26、52周进行。
- 试验注册于荷兰试验注册库NL7504,注册日期2019年2月7日。
主要发现
- 主要结局为每4周偏头痛天数,以头痛日记评估。
- 次要结局包括偏头痛发作次数、药物使用、头痛所致失能、头痛强度及报告偏头痛减少50%的受试者数。
- 次要结局还包括颈椎压痛阈值、异常性疼痛、颈屈肌耐力、缺勤天数与总体感知疗效。
关键数值与推荐
- 多模式MT干预包括手法按压技术、颈部肌肉力量训练及颈胸椎松动。
- 主要结局指标为每4周偏头痛天数。
临床怎么用
- 若结果阳性,多模式MT可作为不愿每日服用预防性药物的偏头痛患者的非药物选择。
- 全科医生常规照护组按荷兰全科医生头痛指南处理。
局限性
- 本文为试验设计报告,尚未报告疗效结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: People with migraine often experience disability with serious consequences for their social life and work productivity. The pharmacological prophylactic management of migraine is effective in reducing migraine attacks. However, many people are reluctant to use daily prophylactic medication, leading to a demand for non-pharmacological treatment options. We present the design for and discuss the feasibility of a pragmatic, randomized controlled trial on the effectiveness of a multimodal manual therapy (MT) treatment compared to usual care by the general practitioner (GP) for the prophylactic treatment of migraine. METHODS: Eligible participants will be recruited in primary care using the International Classification of Headache Disorders III criteria for migraine of the International Headache Society. Participants will be randomized to either multimodal MT treatment or usual care provided by the GP. GPs will be asked to treat the usual care group according to the Dutch GP guideline for headache. The multimodal MT intervention will include manual pressure techniques, neck muscle-strength exercises and mobilization of the cervical and thoracic spine. The trial will consist of a 12-week treatment period and follow-up measurements at 12, 26 and 52 weeks. The primary outcome measure is the number of migraine days per 4 weeks, assessed with a headache diary. Secondary outcome measures are the number of migraine attacks, medication use, disability due to headache, headache intensity, number of participants reporting a 50% migraine reduction, measurement of cervical pressure pain thresholds, presence of allodynia, endurance of cervical flexor muscles, days of absence of work and global perceived effect. DISCUSSION: The results of the trial will show whether a multimodal MT intervention is an effective non-pharmacological treatment option for people with migraine. TRIAL REGISTRATION: Dutch Trial Register, NL7504. Registered on 7 February 2019.
引用
- Amons AL, Castien RF, van der Wouden JC, et al. Manual therapy as a prophylactic treatment for migraine: design of a randomized controlled trial. Trials. 2019. PMID: 31881911. doi:10.1186/s13063-019-3937-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。